Past Air, Inc. XAIR will launch its fourth-quarter monetary outcomes after the closing bell on Tuesday, June 17.
Analysts count on the Backyard Metropolis, New York-based firm to report quarterly income of $1.39 million, in comparison with $470,000 a yr earlier, in response to knowledge from Professional to gasoline.
On April 21, Past Air introduced its NeuroNOS subsidiary was granted an FDA Orphan Drug Designation.
Past Air shares fell 3% to shut at $0.1779 on Friday.
Benzinga readers can entry the most recent analyst rankings on the Analyst Inventory Scores web page. Readers can type by inventory ticker, firm identify, analyst agency, ranking change or different variables.
Let’s take a look at how Benzinga’s most-accurate analysts have rated the corporate within the latest interval.
Right now’s Greatest Finance Offers
BTIG analyst Marie Thibault downgraded the inventory from Purchase to Impartial on June 25, 2024. This analyst has an accuracy charge of 63%.
Truist Securities analyst Gregory Fraser maintained a Purchase ranking and lowered the worth goal from $10 to $8 on April 30, 2024. This analyst has an accuracy charge of 63%.
Contemplating shopping for XAIR inventory? Right here’s what analysts suppose:
Learn This Subsequent:
Picture through Shutterstock
Inventory Rating Locked: Wish to See it?
Benzinga Rankings provide you with important metrics on any inventory – anytime.
Reveal Full ScoreMarket Information and Information dropped at you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
